• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Ethereum Researchers Introduce SPHINCS for Quantum-Resistant Signatures

chest

Ethereum researchers introduce SPHINCS, a post-quantum signature design for enhancing wallet security against quantum computing threats.

user avatarDavid Robinson

Bitcoin Faces Major Liquidation Event Amid Price Fluctuations

chest

Bitcoin traders faced significant liquidations as the price fluctuated sharply, resulting in nearly $980 million in liquidations within 24 hours.

user avatarMaria Gutierrez

Sky Governance Forum Emphasizes Editorial Policy

chest

The Sky Governance Forum has established a strict editorial policy that focuses on accuracy, relevance, and impartiality.

user avatarAndrew Smith

Ethereum Derivatives Show Bearish Sentiment as Funding Turns Negative

chest

Ethereum derivatives have experienced negative funding rates since June 5, indicating a bearish bias in the market.

user avatarJacob Williams

Crypto Derivatives Traders Show Caution After Bitcoin Selloff

chest

Crypto derivatives traders have become more cautious following a significant selloff, as indicated by the Block Scholes Risk Appetite Index dropping below 0.05.

user avatarZainab Kamara

Strategy Inc Conducts First Bitcoin Sale Since 2022

chest

Strategy Inc sold 32 BTC in late May 2023 for approximately $2.1 million to fund preferred dividend payments.

user avatarAyman Ben Youssef

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.